Anubha Mahajan
Distinguished Scientist in Human Genetics, Translational Medicine, Research Biology @Genentech
Signup · Get unlimited contacts
WORK HISTORY
Distinguished Scientist in Human Genetics, Translational Medicine, Research Biology @Genentech
Lead a scientific program integrating human genetics with proteomics, transcriptomics, and spatial transcriptomics to advance mechanistic understanding and target validation in Alzheimer’s disease.Develop multi-omic frameworks connecting genetic association to gene, mechanism, and therapeutic hypothesis generation.Apply AI-enabled knowledge integration and autonomous analytical approaches to synthesize complex, multi-modal human datasets.Lead a pan-Roche UK Biobank proteomics initiative to advance proteogenomic strategies and embed multi-omic human evidence into translational decision-making.Mentor and develop a high-performing team operating at the intersection of genetics, multi-omics, and drug discovery.
EDUCATION
St Xavier's College, Mumbai University
BSc, Microbiology/Biochemistry
Panjab University
MSc, Biotechnology
Delhi University
PhD, Biomedical Sciences
ABOUT ANUBHA MAHAJAN
Human genetics is transforming how we understand disease and how we build medicines. My work focuses on translating large-scale human data into therapeutic insight — connecting genetic association to gene, mechanism, and ultimately, clinical intervention.As a Distinguished Scientist at Genentech (Roche), I lead a scientific program integrating human genetics with proteomics, transcriptomics, and spatial transcriptomics to dissect complex disease biology, with current emphasis in Alzheimer’s disease. By combining multi-omic evidence with AI-enabled knowledge integration and autonomous analytical approaches, we are building frameworks that accelerate mechanism-to-target translation and strengthen the biological foundation of drug development decisions.In parallel, I focus on advancing proteogenomic approaches that integrate genetic and proteomic evidence to strengthen target validation and mechanistic insight. As part of this work, I lead a pan-Roche UK Biobank proteomics initiative embedding multi-omic human data more systematically into translational decision-making.My early work in type 2 diabetes genetics shaped how I think about disease biology. Across disease areas, I remain guided by the same principle: that grounding decisions in rigorous human data is one of the most powerful ways to improve how we develop medicines.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.